Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota

Objective: To evaluate the protective effect of Polyethylene Glycol Loxenatide Injection (Glucagon-like peptide-1, GLP-1) on endothelial cells from middle-aged and elderly patients with newly diagnosed or poorly controlled type 2 diabetes mellitus (T2DM). GLP-1 weekly formulation was analyzed for ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fengwu, He, Lina, Li, Jilin, Yang, Shuhui, Zhang, Bangzhou, Zhu, Dan, Wu, Zezhen, Zhang, Shuo, Hou, Ducheng, Ouyang, Cong, Yi, Jianfeng, Xiao, Chuanxing, Hou, Kaijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240776/
https://www.ncbi.nlm.nih.gov/pubmed/35782875
http://dx.doi.org/10.3389/fmolb.2022.879294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240776/
https://www.ncbi.nlm.nih.gov/pubmed/35782875
http://dx.doi.org/10.3389/fmolb.2022.879294

Ejemplares similares